Landmark Bancorp just put Q3 2026 on the board with another solid profit print, and the market barely shrugged. The stock edged up only 0.6% to about $32 even as earnings per share landed near $0.90 and net interest margin, the lifeblood of a community bank, moved higher.
That muted reaction suggests sentiment is still cautious. Traders appear more focused on short term noise than on a bank quietly widening its spread on loans and deposits. For long term holders, the key question is whether this margin strength proves durable, not today’s small price move.
Love Landmark Bancorp’s firm margin and earnings print but wish you had a wider bench of banks with strong spreads and solid fundamentals on your radar too? Take a look at our curated screener of resilient financials through the list of solid balance sheet and fundamentals stocks (23 results)
Q3 2026 Earnings Summary
- Revenue (Q3 2026 vs. Q3 2025): US$19.039m vs. US$17.312m (up 10.0%)
- Net Income (Q3 2026 vs. Q3 2025): US$5.474m vs. US$4.93m (up 11.0%)
- Basic EPS (Q3 2026 vs. Q3 2025): US$0.90 vs. US$0.81 (up 10.5%)
- Net Interest Margin, or NIM, (Q3 2026 vs. Q3 2025): 4.35% vs. 3.83% (reflecting a higher spread on earning assets)
Net interest margin hit 4.35% even as loans shrank. Ask Charlie what Landmark Bancorp sees driving loan growth next.
Landmark Bancorp margin story versus growth
For the bullish narrative, Landmark Bancorp now has real support from the numbers. Revenue and net income both moved higher year on year while NIM reached 4.35%, helped by richer loan yields. Credit costs stayed light and nonperforming loans declined as a share of the book. Even with loan balances easing and mortgage fee income softer, earnings power held up. That lines up with the idea of a relationship bank that can defend profitability through pricing discipline rather than chasing every dollar of volume.
Funding, loan trends and the risk lens
The risk focused view still has some backing. Loan balances fell as payoffs outpaced originations and deposits declined, with seasonal public funds outflows replaced by higher wholesale borrowings. That mix can pressure funding costs if it persists. Unrealized losses on securities also pulled book value lower. Credit quality is currently steady, yet rising delinquencies around a single commercial real estate borrower show that concentration risk has not disappeared. These data points mean the cautious narrative on funding and credit cycles remains relevant, even if immediate stresses look contained.
After a funding shift like this and a relatively low allowance for bad loans, it is worth asking whether Landmark Bancorp has other weak spots hiding in plain sight. Review the full risk analysis for Landmark Bancorp which shows 1 important warning signHunt Quiet Disconnects In Quality
Landmark Bancorp just showed how a firmer margin and steady earnings can meet a muted share price reaction. The real opportunity sits in finding stocks that could be undervalued before the market reassesses them.
- Company 1 - 21% below our estimate - uses surgical robotics and higher acuity procedures to deepen its role in complex joint replacements.
- Company 2 - 32% below our estimate - supplies the GPUs and software stack that data center customers rely on to scale AI workloads.
- Company 3 - 20% below our estimate - builds a cardiometabolic and obesity drug portfolio that payers gradually broaden access to support chronic treatment.
Three companies from the same screener. Open the full list of 30 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com